Rationale for choice of lymphodesection tactics in patients with uterine body cancer

dc.contributor.author	Suprunova, T.	en
dc.contributor.author	Lopushanskyi, O.	en
dc.date.accessioned	2025-03-27T11:10:11Z
dc.date.available	2025-03-27T11:10:11Z
dc.date.issued	2022
dc.identifier.citation	Suprunova T. Rationale for choice of lymphodesection tactics in patients with uterine body cancer / T. Suprunova, O. Lopushanskyi // Modern science: innovations and prospects : proceedings of VII International scientific and practical conference, Stockholm, 3–5 April 2022 y. – Stockholm (Sweden), 2022. – P. 17–19.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/9184	en
dc.description.abstract	the last 30 years in Eastern Europe, uterine cancer ranks second in the structure of oncogynecological pathology, and the annual increase in morbidity is estimated at 2–7%. Cancer of the uterine body ranks seventh in the world structure of the incidence of oncogynecological pathology, and in the structure of the incidence of cancer in the female population in the CIS – third place. Unsatisfactory statistical data pose a pressing issue to the modern scientific community of rationalization of treatment methods and, in particular, approaches to the choice of lymph dissection.	en
dc.language.iso	en	en
dc.publisher	SSPG	en
dc.subject	lymph dissection	en
dc.subject	uterine cancer	en
dc.subject	lymph nodes	en
dc.title	Rationale for choice of lymphodesection tactics in patients with uterine body cancer	en
dc.type	Thesis	en